Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

57.34
+1.071.90%
Volume:422.82K
Turnover:24.13M
Market Cap:1.99B
PE:-14.64
High:57.62
Open:56.62
Low:55.99
Close:56.27
Loading ...

Company Profile

Company Name:
Disc Medicine
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
94
Office Location:
321 Arsenal Street,Suite 101,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
- -
Introduction:
Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias, erythropoietic protoporphyria, and X-linked protoporphyria. In addition, the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown, Massachusetts.

Directors

Name
Position
Donald W. Nicholson
Executive Chairman of the Board
John D. Quisel
Director, President and Chief Executive Officer
Georges Gemayel
Independent Director
Kevin Bitterman
Independent Director
Liam Ratcliffe
Independent Director
Mark Chin
Independent Director
Mona Ashiya
Independent Director
William R. White
Independent Director
Nadim Ahmed
Director

Shareholders

Name
Position
John D. Quisel
Director, President and Chief Executive Officer
Jonathan Yu
Chief Operating Officer
Jean M. Franchi
Principal Accounting Officer, Chief Financial Officer and Treasurer
Donald W. Nicholson
Executive Chairman of the Board
Pamela Stephenson
Chief Commercial Officer
Rahul Khara
Chief Legal Officer
William Savage
Chief Medical Officer